Core Viewpoint - North Chip Life (688712.SH) reported a significant increase in revenue and profit for the fiscal year 2025, indicating strong business growth and successful international expansion [1] Financial Performance - The company achieved an operating revenue of 542.11 million yuan, representing a year-on-year growth of 71.23% [1] - The net profit attributable to the parent company was 80.62 million yuan, with a net profit excluding non-recurring gains and losses of 65.14 million yuan, marking a turnaround from losses in the previous year [1] Product and Market Expansion - The company's core products have gained widespread recognition from domestic and international experts due to their significant clinical value and differentiated innovation [1] - The products are now utilized in over 60 countries and regions globally, with clinical applications in more than 2,000 hospitals [1] - Revenue from overseas operations grew by over 130% year-on-year, further increasing the proportion of international business in the company's overall revenue [1]
北芯生命(688712.SH)2025年度归母净利润8062.19万元